FUND DEVELOPMENT COMMITTEE

The Fund Development Committee (FDC): defines the annual and long-term funding needs of the organization, including the development of all funding sources (e.g. Industry Partnership Program, Partner Circle Program, Annual Conferences); establishes fundraising performance goals and major strategies to reach those goals and annual targets; and determines budgets, pricing, and fees for meetings, conferences, and other programs based.

Charlotte Kremer

Charlotte Kremer

MAPS Board Chair | Former EVP and Head of Medical Affairs, Astellas

Andy Greenspan

Andy Greenspan

(Fund Development Committee Member)

VP, Medical Affairs, Immunology, Janssen

Margaret Heim

Margaret Heim

(Innovative Revenue Streams Subcommittee Chair)

Global Healthcare Executive-Multinational Global Medical Affairs Leadership

Jan Schadrack

Jan Schadrack

(Fund Development Committee Member)

Global TA Head Neuroscience & Rare Diseases, Medical, Roche

Anna Walz

Anna Walz

(MAPS Director)

Founder & Chief Executive Officer Emeritus, MedEvoke Senior Strategic Advisor, MEDISTRAVA (Medical Division of Huntsworth)